Laudette et al. in their review have also discussed the deleterious effects of Epac in cardiovascular and pulmonary systems, and these effects were associated with chronic stimulation of cAMP signalling pathways in conditions like myocardial remodelling, heart failure, and chronic obstructive pulmonary disease. This evidence concerns the gene RAPGEF3 and chronic obstructive pulmonary disease.